Thrombotic microangiopathy complicating bortezomib-based therapy for multiple myeloma

被引：19

作者：

Chan, Kah-Lok ^{[1
]}

Filshie, Robin ^{[1
]}

Nandurkar, Harshal ^{[1
]}

Quach, Hang ^{[1
]}

机构：

[1] St Vincents Hosp, Dept Haematol, Melbourne, Vic, Australia

来源：

LEUKEMIA & LYMPHOMA | 2015年 / 56卷 / 07期

关键词：

HEMOLYTIC-UREMIC SYNDROME; PATIENT;

D O I：

10.3109/10428194.2014.977887

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2185 / 2186

页数：2

共 50 条

[41] An Economic Evaluation of Bortezomib-Based Induction Therapy in Double Transplant Protocols for Newly Diagnosed Multiple Myeloma Patients
Wang, Si-Tien
Duh, Mei Sheng
Huang, Hui
White, Leigh Ann
Chang, Eva
Esseltine, Dixie-Lee
Marantz, Jing L.
BLOOD, 2008, 112 (11) : 831 - 832
[42] Impact of bortezomib-based versus lenalidomide maintenance therapy on outcomes of patients with high-risk multiple myeloma
Bumma, Naresh
Dhakal, Binod
Fraser, Raphael
Estrada-Merly, Noel
Anderson, Kenneth
Freytes, Cesar O.
Hildebrandt, Gerhard C.
Holmberg, Leona
Krem, Maxwell M.
Lee, Cindy
Lekakis, Lazaros
Lazarus, Hillard M.
Mian, Hira
Murthy, Hemant S.
Nathan, Sunita
Nishihori, Taiga
Parrondo, Ricardo
Patel, Sagar S.
Solh, Melhem
Strouse, Christopher
Vesole, David H.
Kumar, Shaji
Qazilbash, Muzaffar H.
Shah, Nina
D'Souza, Anita
Sidana, Surbhi
CANCER, 2023, 129 (14) : 2179 - 2191
[43] In-class transition from bortezomib-based therapy to IRd is an effective approach in newly diagnosed multiple myeloma
Rifkin, Robert M.
Costello, Caitlin L.
Birhiray, Ruemu E.
Kambhampati, Suman
Richter, Joshua
Abonour, Rafat
Lee, Hans C.
Stokes, Michael
Ren, Kaili
Stull, Dawn Marie
Cherepanov, Dasha
Bogard, Kimberly
Noga, Stephen J.
Girnius, Saulius
FUTURE ONCOLOGY, 2024, 20 (03) : 131 - 143
[44] Comparative proteomic profiling of sera from patients with refractory multiple myeloma for predicting response to bortezomib-based therapy
Luczak, Magdalena
Kubicki, Tadeusz
Rzetelska, Zuzanna
Szczepaniak, Tomasz
Przybylowicz-Chalecka, Anna
Ratajczak, Blazej
Czerwinska-Rybak, Joanna
Nowicki, Adam
Joks, Monika
Jakubowiak, Andrzej
Komarnicki, Mieczyslaw
Dytfeld, Dominik
POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2017, 127 (06): : 392 - 400
[45] Comparative proteomic profiling of refractory/relapsed multiple myeloma reveals biomarkers involved in resistance to bortezomib-based therapy
Dytfeld, Dominik
Luczak, Magdalena
Wrobel, Tomasz
Usnarska-Zubkiewicz, Lidia
Brzezniakiewicz, Katarzyna
Jamroziak, Krzysztof
Giannopoulos, Krzysztof
Przybylowicz-Chalecka, Anna
Ratajczak, Blazej
Czerwinska-Rybak, Joanna
Nowicki, Adam
Joks, Monika
Czechowska, Elzbieta
Zawartko, Magdalena
Szczepaniak, Tomasz
Grzasko, Norbert
Morawska, Marta
Bochenek, Maciej
Kubicki, Tadeusz
Morawska, Michalina
Tusznio, Katarzyna
Jakubowiak, Andrzej
Komarnicki, Mieczyslaw
ONCOTARGET, 2016, 7 (35) : 56726 - 56736
[46] Evaluation of neutrophil-to-lymphocyte ratio in newly diagnosed patients receiving bortezomib-based therapy for multiple myeloma
Zhou, Xin
Wang, Jing
Xia, Jun
Cheng, Feng
Mao, Jingjue
Zhu, Jianwei
Guo, Hongfeng
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2018, 42 : S5 - S5
[47] Dramatic results seen in phase III front-line multiple myeloma trials of bortezomib-based therapy
不详
ONCOLOGY-NEW YORK, 2008, 22 (01): : 80 - 81
[48] Combined immune score predicts the prognosis of newly diagnosed multiple myeloma patients in the bortezomib-based therapy era
Wei, Min
Guo, Honggang
Liu, Siwei
Xu, Fangfang
Zhang, Yin
Shi, Jie
Xu, Zhiwei
Chen, Yuqing
MEDICINE, 2021, 100 (41) : E27521
[49] Association Of Stringed Response and Immunoparesis Normalization After Bortezomib-Based Therapy Is Related To Better Outcomes In Multiple Myeloma
Andrade, Marcio M., Sr.
Murillo-Florez, Ilda
Montes-Limon, Anel
de Rueda, Beatriz
Grasa, Jose-Maria
Giraldo, Pilar
BLOOD, 2013, 122 (21)
[50] Treatment of newly diagnosed myeloma: Bortezomib-based triplet
Rajan, Archana M.
Rajkumar, S. Vincent
SEMINARS IN ONCOLOGY, 2016, 43 (06) : 700 - 702

← 1 2 3 4 5 →